This content is from: Regulation
OTC regulation in Asia: where are we now?
Regulators across the Asia-Pacific are preparing to implement rules for clearing OTC derivatives transactions. But many jurisdictions are stumbling on legal issues
To access our in-house intelligence please request a trial here.
Read this article – and more – for a 30 day period.
REQUEST ACCESSAre you already an IFLR subscriber? Login here